Cargando…
1425. Population Pharmacokinetic Analysis of Ciprofloxacin and Levofloxacin in Critically Ill Trauma, Surgical, and Burn Patients
BACKGROUND: Antibiotic pharmacokinetics (PK) differ between critically ill and noncritically ill patients, as do the bacteria causing infection, yet dosing regimens are derived from noncritically ill populations. The purpose of this study was to examine the adequacy of ciprofloxacin and levofloxacin...
Autores principales: | Ivins-O’Keefe, Kelly, Akers, Kevin S, Schlotman, Taylor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253536/ http://dx.doi.org/10.1093/ofid/ofy210.1256 |
Ejemplares similares
-
Comparison of Piperacillin and Tazobactam Pharmacokinetics in Critically Ill Patients with Trauma or with Burn
por: Selig, Daniel J., et al.
Publicado: (2022) -
653. Diagnosis of Burn Sepsis Using the FcMBL ELISA: A Pilot Study in Critically Ill Burn Patients
por: Akers, Kevin S, et al.
Publicado: (2019) -
Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients
por: Abdulla, Alan, et al.
Publicado: (2020) -
Pharmacokinetics and the optimal regimen for levofloxacin in critically ill patients receiving continuous hemodiafiltration
por: Wada, Takeshi, et al.
Publicado: (2015) -
Meropenem pharmacokinetics in critically ill patients with or without burn treated with or without continuous veno‐venous haemofiltration
por: Selig, Daniel J., et al.
Publicado: (2021)